with highest class III obesity prevalence, and bottom sextile (S6) had the three hospitals with the lowest prevalence. The prevalence of class III obesity was 9.1% in S1 and 1.3% in S6. Controlling for the baseline CD rate at each individual hospital, the odds of a woman with class III obesity experiencing a primary NTSV CD was approximately 1.5 fold higher among hospitals in S6 compared to those in S1 (OR 1.46, 95% CI 1.02 e 2.11, p¼0.04). CONCLUSION: Our data demonstrates that institutional level experience with class III obesity influences the primary NTSV CD rate in this high risk population. As we continue to optimize the primary CD rate, these results support the concept of regionalization of care for women with class III obesity. Further studies are needed to evaluate factors that could be contributing to this variance between hospital settings. Patients with indications for a fetal echocardiogram, according to the AIUM guideline, were identified from medical records. Among patients with indications for a fetal echocardiogram, we compared the proportions of those who underwent the study among the various racial groups and the different practice types separately. We then applied logistic regression to assess the effect of race and practice type altogether to account for potential confounding. RESULTS: There were 3,375 patients who received all of their prenatal care at our center during the study period. Race data was available for 3,105. We found significant differences in the proportions of patients with at least one indication for fetal echocardiogram when compared by practice type (p<0.0001) and in adherence to the guidelines by practice type (p<0.0001). The MFM practice (43.7%) and academic high-risk clinic (38.5%) had significantly higher proportions of patients with indications for fetal echocardiography compared to the other practice types. Compared to patients in any other practice, adherence was significantly higher in the MFM practice (93.2%), and lowest in the academic low-risk clinic (60.0%) when compared to all groups apart from the affiliated low-risk clinics. There was no difference in adherence between other practices.
261 Adherence to fetal echocardiography guidelines at an academic center: variation by practice type and race/ethnicity OBJECTIVE: To determine the proportion of patients with indications for fetal echocardiography who underwent the examination and to compare adherence between the practice types and among patient racial and ethnic groups at a large teaching hospital. STUDY DESIGN: We performed a retrospective cohort study of all obstetric patients who received prenatal care at Columbia University Medical Center from January 1 st , 2016 to December 31 st , 2016. Patients with indications for a fetal echocardiogram, according to the AIUM guideline, were identified from medical records. Among patients with indications for a fetal echocardiogram, we compared the proportions of those who underwent the study among the various racial groups and the different practice types separately. We then applied logistic regression to assess the effect of race and practice type altogether to account for potential confounding. RESULTS: There were 3,375 patients who received all of their prenatal care at our center during the study period. Race data was available for 3,105. We found significant differences in the proportions of patients with at least one indication for fetal echocardiogram when compared by practice type (p<0.0001) and in adherence to the guidelines by practice type (p<0.0001). The MFM practice (43.7%) and academic high-risk clinic (38.5%) had significantly higher proportions of patients with indications for fetal echocardiography compared to the other practice types. Compared to patients in any other practice, adherence was significantly higher in the MFM practice (93.2%), and lowest in the academic low-risk clinic (60.0%) when compared to all groups apart from the affiliated low-risk clinics. There was no difference in adherence between other practices.
We found no difference in race distribution by practice type and no difference in adherence when stratified by racial/ethnic group. Practice type remains a significant predictor of adherence after adjusting for race (p<0.0024). Overall, 53 cases of congenital heart disease were detected prenatally during the study period, representing 1.6% of our patients. CONCLUSION: We did not identify a disparity in the adherence to fetal echocardiography guidelines among racial groups. Adherence was highest among patients in the MFM practice and lowest in the lowrisk academic clinic, demonstrating that even in a large teaching hospital, disparities exist between practice types in the underutilization of fetal echocardiography.
262 Improving error identification with an inpatient maternal-fetal medicine pharmacist OBJECTIVE: Although the fast-paced environment of inpatient obstetrics may predispose to medication errors, there is relatively little information about their nature and frequency. In September 2017, our Midwestern level-IV hospital hired a dedicated inpatient maternal-fetal medicine clinical pharmacy specialist. The pharmacist attends daily board rounds on labor and delivery, rounds on all antepartum patients, and monitors medication orders. The objectives of this quality improvement study were to: (1) quantify the number and types of interventions made by the pharmacist and (2) to compare rates of reported errors before and after her hiring. We hypothesized that the rate of identified medication errors would be increased in the time period after the pharmacist was employed. STUDY DESIGN: From February 1, 2018 through May 31, 2018, the pharmacist tabulated her interventions on a daily basis under the categories of medication error, drug interactions, monitoring, cost savings, medication management, and other. The number and types of medication errors reported to our institutional event reporting system in the eight months prior to and first eight months after the pharmacist's hiring were compared. RESULTS: Figure 1 depicts the number of interventions (n¼1,217) within the different categories per month. The most frequent interventions were discontinuation of medications that were no longer indicated (n¼232), providing drug information/education of clinical staff (n¼251), and providing initial dose recommendations (n¼116). There were 74 cost-saving interventions. The number of reported medication errors (n¼71) to the centralized reporting system doubled (3/month to 6/month, p¼0.007) after the pharmacist's hiring (Figure 2) , and the majority of these were reported by the pharmacist herself. The most frequent types of errors were wrong dose, route, or schedule (n¼33) and medication not given or given without order (n¼18). CONCLUSION: In the initial months after commencing her role, the pharmacist provided over 1,000 direct clinical interventions to improve patient care in a high-risk environment. Furthermore, medical errors can only be systematically addressed when they are noticed, and this study highlights that a significant proportion of medication errors (50% in this study) are not reported by providers. These results suggest the addition of a pharmacist to the obstetric team may lead to interventions which ultimately improve medication safety.
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